Close Menu

cell-based assays

NEW YORK (GenomeWeb News) – Biotech firm Odyssey Thera has raised $2.8 million and initiated a research service contract with Merck, it announced on Thursday.

NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

Cytoo will later this month introduce its 2D+ cell culture platform and accompanying custom services, according to a company spokesperson.

NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and Cellular Dynamics today announced a licensing deal allowing CDI to develop, manufacture, and sell cellular assays and models derived from induced pluripotent stem cells for drug discovery and toxicity screening.

NEW YORK (GenomeWeb News) – Cisbio Bioassays today announced a deal to distribute BellBrook Labs' Transcreener Epigen Methyltransferase assay.

NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening. Financial terms of the deal were not disclosed.

NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.

This story was originally posted on Oct. 18
Cytoo, a French life sciences tools provider, will soon launch a microplate version of its CytooChips Motility chip for studying cell migration, according to a company spokeperson.

NEW YORK (GenomeWeb News) – Cellectricon and Fluxion Biosciences announced today they have settled a legal dispute dating back to 2009 in which Fluxion was accused of patent infringement.

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute plans to provide $5 million over the next two years to fund research projects aimed at developing better and cheaper methods for screening genetic variants that play roles in diseases.

Pages

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.